≡

Multiplex Assay Kit for TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD202b; CD202-B; TEK; VMCM1; Tyrosine Kinase With Immunoglobulin Like And EGF Like Domains 2; Venous Malformations Multiple Cutaneous And Mucosal

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 88-104 97
EDTA plasma(n=5) 87-95 91
heparin plasma(n=5) 95-103 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 89-96% 81-101% 80-93% 81-94%
EDTA plasma(n=5) 94-101% 84-103% 85-93% 85-99%
heparin plasma(n=5) 87-104% 92-101% 78-99% 89-96%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:Tie2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Anesthesiology Vasculotide, an angiopoietin-1 mimetic, restores microcirculatory perfusion and microvascular leakage and decreases fluid resuscitation requirements in … Pubmed:28968277
British Journal of Anaesthesia Vasculotide, an angiopoietin-1 mimetic, reduces pulmonary vascular leakage and preserves microcirculatory perfusion during cardiopulmonary bypass in rats 10.1016:j.bja.2018.05.049
Intensive Care Med Exp The effect of targeting Tie2 on hemorrhagic shock-induced renal perfusion disturbances in rats 33997943
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPA126Ra01 Recombinant TEK Tyrosine Kinase, Endothelial (Tie2) Positive Control; Immunogen; SDS-PAGE; WB.
PAA126Ra01 Polyclonal Antibody to TEK Tyrosine Kinase, Endothelial (Tie2) WB; IHC; ICC; IP.
MAA126Ra21 Monoclonal Antibody to TEK Tyrosine Kinase, Endothelial (Tie2) WB; IHC; ICC; IP.
SEA126Ra ELISA Kit for TEK Tyrosine Kinase, Endothelial (Tie2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA126Ra Multiplex Assay Kit for TEK Tyrosine Kinase, Endothelial (Tie2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.